Tradename | Company | Number | Date | Products |
---|---|---|---|---|
FERIDEX I.V. | AMAG Pharmaceuticals | N-020416 DISCN | 1996-08-30 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
feridex | 2008-03-10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 2 | 2 | 1 | 5 | 10 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sentinel lymph node biopsy | D021701 | — | — | 1 | 2 | 1 | — | 3 | 6 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | — | 1 | — | 2 | 4 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | 1 | — | 1 | 2 |
Prostatic neoplasms | D011471 | — | C61 | 1 | 1 | 1 | — | — | 2 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 1 | 1 | — | 1 | 2 |
Infarction | D007238 | EFO_0009463 | — | — | 1 | 1 | — | 1 | 2 |
Carcinoma in situ | D002278 | — | D09.9 | — | — | 1 | — | — | 1 |
Intraductal carcinoma noninfiltrating | D002285 | — | D05.1 | — | — | 1 | — | — | 1 |
Prostatectomy | D011468 | — | — | — | — | 1 | — | — | 1 |
Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Urinary bladder neoplasms | D001749 | — | C67 | 2 | 1 | — | — | — | 2 |
Magnetic resonance imaging | D008279 | — | — | 2 | 1 | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | — | 1 |
Uterine neoplasms | D014594 | EFO_0003859 | C55 | 1 | 1 | — | — | — | 1 |
Uterine cervical neoplasms | D002583 | HP_0030159 | — | 1 | 1 | — | — | — | 1 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 2 | — | — | — | — | 2 |
Inflammation | D007249 | MP_0001845 | — | 1 | — | — | — | 1 | 2 |
Sclerosis | D012598 | — | — | 2 | — | — | — | — | 2 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | — | — | — | — | 1 |
Osteosarcoma | D012516 | — | — | 1 | — | — | — | — | 1 |
Head and neck neoplasms | D006258 | — | — | 1 | — | — | — | — | 1 |
Coronary disease | D003327 | — | — | 1 | — | — | — | — | 1 |
Coronary artery disease | D003324 | — | I25.1 | 1 | — | — | — | — | 1 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | 1 | — | — | — | — | 1 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphatic metastasis | D008207 | EFO_1001364 | — | — | — | — | — | 2 | 2 |
Melanoma | D008545 | — | — | — | — | — | — | 2 | 2 |
Healthy volunteers/patients | — | — | — | — | — | — | — | 2 | 2 |
Thyroid neoplasms | D013964 | EFO_0003841 | — | — | — | — | — | 1 | 1 |
Papillary thyroid cancer | D000077273 | — | — | — | — | — | — | 1 | 1 |
Thyroid diseases | D013959 | HP_0000820 | E00-E07 | — | — | — | — | 1 | 1 |
Follicular adenocarcinoma | D018263 | — | — | — | — | — | — | 1 | 1 |
Papillary carcinoma | D002291 | — | — | — | — | — | — | 1 | 1 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | — | — | — | — | 1 | 1 |
Mouth neoplasms | D009062 | EFO_0003868 | C06.9 | — | — | — | — | 1 | 1 |
Drug common name | Ferumoxides |
INN | — |
Description | Feridex I.v. (ferumoxides) is an small molecule pharmaceutical. Ferumoxides was first approved as Feridex I.v. on 1996-08-30. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201502 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | — |